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Introduction	
Echinococcus multilocularis, commonly known as the fox tapeworm, is 
endemic to areas of central and northern Europe, northern Asia and 
parts of North America. The life cycle is primarily sylvatic, involving 
foxes and small herbivores such as voles, but the domestic dog can 
also act as a definitive host. Aberrant infection of humans results in 
alveolar echinococcosis, a debilitating and possibly fatal disease. A 
thorough knowledge of the life cycle of this parasite and its control 
underpins its successful exclusion from Ireland and reinforces the 
importance of prior praziquantel treatment of imported animals. 
life	cycle			
Although the red fox and the arctic fox are the most well-known 
definitive hosts, others include the coyote, racoon dog, sand fox 
and Tibetan fox. Other canids, including the domestic dog, can also 
become definitive hosts if they ingest an intermediate host harbouring 
the infective metacestode. Cats are capable of acting as aberrant 
definitive hosts with low or negligible egg excretion. The principal 
intermediate hosts are small herbivores or insectivores: voles, 
squirrels, hamsters, mice, jerboas, shrews and, occasionally, moles and 
desmans. 
Infection in the definitive host is often asymptomatic. The adult stage 
of Echinococcus multilocularis is a cestode similar in appearance to 
Echinococcus granulosus. The cestode is 1.2mm to 4.5mm long, usually 
with five segments (there is a range of two to six) terminating in a 
sac-like ‘uterus’ (Figure	1). Adults are resident deep into the crypts 
of Lieberkuhn of the intestinal mucosa where they cause flattening, 
but not disruption, of the epithelium. As there are no gross intestinal 
lesions, there are few or no ill effects on definitive hosts, even in the 
face of a heavy burden. 
The prepatent period is unclear but eggs are thought to be excreted 
by definitive hosts from day 35. Eggs are immediately infective and 
infection of the intermediate host occurs through ingestion. Within 
the intermediate host, metacestodes develop primarily in the liver 
but occasionally they are found in other organs, including the lungs 
and central nervous system. This metacestode stage consists of 
aggregations of small vesicles (‘hydatid cysts’) in which infective 
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protoscoleces are produced. The cysts vary in size, shape and 
number and aggregate to form alveolar structures 1mm to 30mm in 
diameter, containing a variable number of protoscoleces that have 
the capacity to proliferate and progressively invade the surrounding 
host tissue. During this process the parasite is protected from the 
host immune response by its carbohydrate-rich laminated layer. 
Metacestode development is well adapted to the naturally short-
lived intermediate hosts and protoscoleces are produced in 40 to 45 
days. In experimental models natural intermediate hosts will die from 
the consequences of parasitic organ infiltration about five months 
following infection. However, in the wild the host might succumb to 
predation by a carnivore before this occurs.  
A wide variety of species has been observed to act as aberrant 
intermediate hosts such as rodents, lagomorphs, domestic and wild 
pigs, domestic dogs, domestic cats, monkeys, horses and humans. 
In fact, there are reported occurrences of individual dogs acting as 
both definitive and intermediate host concurrently. The development 
of the metacestode in these aberrant intermediate hosts is similar 
to that in the natural intermediate host with the coalescence of 
numerous hepatic vesicles to form alveolar structures. Local tissue 
invasion results in hepatic and other organ dysfunction. Dogs have 
been reported to present with abdominal enlargement, ascites and 
hypergammaglobulinaemia.
Epidemiology	and	control	in	endemic	countries	
Echinococcus multilocularis is endemic to areas of France, Spain, 
Portugal, Greece, Germany, Austria, Switzerland, Belgium, the Czech 
Republic, Denmark, Liechtenstein, Luxembourg, Poland and the Slovak 
Republic. This range then extends east as far as Japan, Canada and the 
northern United States and is proposed to include parts of north 
Africa. The principal reservoir of infection is the native fox population, 
although in some areas self-perpetuating reservoirs exist in domestic 
dogs. Young foxes and dogs tend to have the heaviest burdens, but 
older animals can also be infected regardless of prior exposure. 
Infection of domestic pets with  Echinococcus multilocularis has 
been documented throughout Europe. For example, prevalence of 
infestation in the domestic dog and cat populations in France and 
Germany is estimated, from necropsy studies, to be 0.4% to 5.6%. 
Necropsy studies, however, will tend to overestimate prevalence in 
a population. Newer faecal coproantigen tests on randomly selected 
Swiss dogs and cats give a prevalence of 0.3% in dogs (rising to 7% 
in urban populations) and of 0.4% in cats (rising to 3% in urban 
populations). Many of these areas were previously perceived to be 
free from the parasite. These trends of increasing prevalence may be 
due to increased diagnostic accuracy or, more likely, to the spread of 
the parasite’s range, associated with increasing urban fox population 
or travel of infected dogs. Irrespective of cause, this increased parasite 
density constitutes an increased risk to domestic pets and to the 
human population.  
Control of Echinococcus multilocularis in domestic pets living in 
countries where the disease is endemic involves a combination of 
routine anthelminthic use, public area hygiene, control of the stray 
dog population and, perhaps most importantly, public education. In 
addition, there have been efforts to control infection in the wild 
fox population in Germany with aircraft-dropped baits spiked with 
praziquantel, which have been more successful than fox culling 
programmes.
diagnosis	and	treatment 
Briefly, diagnosis in intermediate and definitive hosts uses a number 
of techniques to achieve cestode identification. Unfortunately, 
routine coprological microscopic examination does not allow the 
differentiation of Echinococcus and Taenia spp eggs thus serology, 
faecal antigen ELISA or PCR are required. In living patients, ultrasound 
examination of abdominal organs or the characteristic cysts may be 
beneficial in achieving a diagnosis.
Because  domestic  dogs  and  cats  with  intestinal  Echinococcus 
multilocularis represent a potential risk to humans, infected animals 
Figure	1:	Adult E.multilocularis. Photo: Institute of Parasitology, University of Zurich.
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should  be  treated  immediately. A  single  dose  of  praziquantel 
(Appendix	1) virtually eliminates the entire worm burden. 
Confirmed infected cases should receive two doses on consecutive 
days and, four or five days afterwards,  the results should be assessed 
by coproantigen ELISA.
Owners of infected dogs should be advised to contact their doctor 
for serological testing within several weeks, and for this to be 
repeated in six and 12 months.
Human	alveolar	echinococcosis	 
Human infection is sporadic and possibly fatal. In Europe, human 
alveolar  echinococcosis  occurs  at  a  prevalence  ranging  from 
0.03 (Austria) to 1.4 (Doubs, France) per 100,000 members of 
the population. The majority of cases are thought to be due to 
environmental or food contamination with infected fox or dog faeces 
and poor hygiene precautions. Eggs can survive for up to eight months 
in winter conditions and three months in summer.
Alveolar echinococcosis follows ingestion of eggs that have been shed 
in the faeces of a definitive host. The initial phase, characterised by 
development of small well-encapsulated hepatic cysts, is asymptomatic, 
but local infiltration and secondary cyst development at distant sites 
occur progressively with resultant clinical signs. The incubation period 
prior to clinical symptoms is prolonged, perhaps five to 15 years 
and clinical symptoms only occur when large parts of the liver are 
already infiltrated (Figure	2). Patients with infiltrative liver disease 
present with cholestatic jaundice, epigastric pain, fatigue, weight loss 
and hepatomegaly. Treatment is rarely curative and involves partial 
or radical surgical resection of lesions with long-term or life-long 
treatment with a benzimidazole, specifically albendazole. Some cases 
require liver transplantation. Long-term treatment is well tolerated 
but is parasitistatic not parasiticidal. 
Risk	factors	for	the	travelling	pet		
The authors are not aware that risk factors for pets travelling to, or 
imported from, countries where Echinococcus multilocularis is endemic 
have been characterised. Logic would dictate that dogs and cats should 
be prevented from hunting and consuming small herbivores. Ingestion 
of fox faeces could result in the pet becoming an intermediate host 
and whilst this would pose no zoonotic risk, nor risk of introduction 
of the disease to Ireland, clinical signs would result. Zoonotic risk is 
perhaps greatest when bathing pet dogs that have rolled in fox faeces; 
strict personal hygiene should be observed. 
At present, maintenance of Ireland’s disease-free status is dependant 
on strict adherence to the pre-treatment of pets entering Ireland 
with praziquantel, at appropriate doses, 24 to 48 hours prior to entry 
into the country. In addition,  it would be prudent to ensure that all 
pets’ coats are free of fox faeces. Should these rules not be adhered 
to, Echinococcus multilocularis infestation in an imported domestic pet 
poses both a zoonotic risk and the risk of introduction of this disease 
into the domestic pet or fox population. Furthermore, diagnosis 
and treatment of Echinococcus multilocularis in a travelled pet should 
hopefully never be required, if the requirement for worming with 
praziquantel 24 to 48 hours prior to return to Ireland is observed.
conclusions		
Whilst infection in the definitive host is of little clinical significance, 
the potential ramifications of introduction of Echinococcus multilocularis 
into the Irish dog and fox populations are immense. The disease is 
zoonotic, often incurable and potentially fatal. Strict adherence to the 
routine worming of travelled dogs with praziquantel, at appropriate 
doses, 24 to 48 hours prior to entry into the country will minimise 
the likelihood of introduction of this potentially devastating disease. 
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Figure	2:	Human liver with alveolar echinococcosis. Photo: Institute of 
Parasitology, University of Zurich.
Appendix	1:	Appropriate praziquantel dosages in pets.
Appendix	1
Praziquantel (Droncit, Bayer and others) 
Dogs   5.0 mg/kg PO
                 5.7 mg/kg IM 
Cats   8.0 mg/kg  Topical formulation
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